Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 15/20 | 0.67 |
| ▸ | HTR2C | P28335 | 9/20 | 0.65 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | BCR | P11274 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4794769 | 0.92 | HTR2A (0.67) | HTR2AHTR2CKCNH2ABL1BCR | |
| SCHEMBL4784431 | 0.92 | HTR2A (0.66) | HTR2AHTR2CKCNH2ABL1BCR | |
| SCHEMBL14205805 | 0.91 | HTR2A (0.55) | HTR2AHTR2CKCNH2MAPTMAPK1 | |
| SCHEMBL4782015 | 0.88 | HTR2A (0.61) | HTR2AHTR2CKCNH2MAPTMAPK1 | |
| SCHEMBL4732167 | 0.88 | HTR2A (0.65) | HTR2AHTR2CKCNH2ABL1BCR | |
| SCHEMBL14205208 | 0.87 | HTR2A (0.61) | HTR2AHTR2CKCNH2 | |
| SCHEMBL4782575 | 0.86 | HTR2A (0.65) | HTR2AHTR2CKCNH2ABL1BCR | |
| SCHEMBL4781852 | 0.85 | HTR2A (0.66) | HTR2AHTR2CKCNH2ABL1BCR | |
| SCHEMBL4781280 | 0.85 | HTR2A (0.66) | HTR2AHTR2CKCNH2MAPT | |
| SCHEMBL4783780 | 0.85 | HTR2A (0.59) | HTR2AHTR2CKCNH2ABL1BCR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008054748-A2 | INDAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2008-05-08 | — | — | WO | claimed |